Skip to main content

Table 2 pCR and response rates in tissue or only lymph nodes in “control” and “intervention” groups

From: Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial

Response group P value
control n = 27
n (%)
intervention n = 25
n (%)
pCR 8 (29.6%) 8 (32%) 0.853
Breast tissue 14 (51.9%) 12 (48%) 0.781
Lymph nodes 11 (40.7%) 11 (44%) 0.812
  1. pCR pathologic complete response